Intestinimonas for Prevention of Type 2 Diabetes Mellitus
Clinical trial NCT04495972 · COMPLETED
Trial details
- NCT number
- NCT04495972
- Sponsor
- Caelus Pharmaceuticals BV
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2023-09-12
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.